Mr. Andre Larente reports

DIAGNOS ANNOUNCES THE ENGAGEMENT OF IBN

Diagnos Inc. has engaged Investor Brand Network (IBN) to provide corporate communication and awareness solutions to the corporation.

As per the agreement signed between IBN and Diagnos, IBN is entitled to a monthly compensation of $6,400 (U.S.), payable in advance, in cash, for a period of one year from Jan. 10, 2026. The compensation to IBN will be paid using the corporation's cash.

As part of the services to be rendered to the corporation, IBN will assist Diagnos in refining and strengthening its market awareness profile with the goal of maximizing shareholder value. The main offices of IBN are located in Austin, Tex., United States.

IBN is acting at arm's length to the corporation. As of the date of this announcement, IBN, together with any of its principals, does not have any interest, directly or indirectly, in the securities of the corporation.

The engagement of IBN is subject to the acceptance of the TSX Venture Exchange.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical eye-related health problems. By leveraging artificial intelligence, Diagnos aims to provide more information to health care clinicians to enhance diagnostic accuracy, streamline workflows and improve patient outcomes on a global scale.

We seek Safe Harbor.